Exact Sciences

exactsciences.com

Exact Sciences is a molecular diagnostics company dedicated to eradicating cancer through innovative testing solutions. Their key products include the Cologuard® test, Onco Ex Tra® test, and Oncotype DX® tests, which focus on early detection and personalized treatment guidance for various cancers. The company differentiates itself through its strong emphasis on science-backed solutions and patient-focused insights, supported by a robust research and development framework. With over 4 million people tested in 2023 and operations in over 120 countries, Exact Sciences has established a significant market presence and traction in the cancer diagnostics field.